Our Pricing

Mounjaro Fleet: Your Complete Guide to Accessing Tirzepatide in Hampshire

Published: 3 October 2026

Mounjaro Fleet residents now have convenient access to this licensed weight loss treatment through UK-registered online pharmacies. As a GPhC-registered pharmacy serving Hampshire and across the UK, Cured Pharmacy offers genuine Mounjaro (tirzepatide) injections from £124.99, with prescriptions issued following a free online consultation with our UK clinical team. This comprehensive guide explains how Fleet patients can safely access Mounjaro, what to expect from treatment, and why choosing a registered pharmacy matters for your health and safety.

What Is Mounjaro Fleet Availability and How Does It Work?

Mounjaro Fleet availability refers to the accessible supply of tirzepatide weight loss injections for residents in Fleet, Hampshire, through legitimate UK-registered pharmacies. Mounjaro is a once-weekly injectable prescription medicine licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. The active ingredient, tirzepatide, works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, regulating appetite and blood sugar levels.

In the SURMOUNT-1 clinical trial, participants taking tirzepatide 15mg achieved an average weight reduction of 20.9% over 72 weeks, significantly outperforming placebo groups [2]. Fleet residents can access Mounjaro through Cured Pharmacy's online service, which includes a comprehensive medical assessment by UK-registered prescribers, ensuring the treatment is clinically appropriate. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all dispensing to guarantee medication authenticity and patient safety.

The convenience of online access means Fleet patients no longer need to visit physical pharmacies for consultations or collections. After completing a confidential online assessment in under three minutes, our clinical team reviews your medical history, BMI, and weight loss goals. If approved, your prescription is dispensed from our GPhC-registered facility and delivered discreetly to your Fleet address, typically within 24-48 hours.

Mounjaro Fleet Pricing: Transparent Costs and UK Comparison

Mounjaro Fleet pricing through Cured Pharmacy starts at £124.99 per treatment cycle, with transparent upfront costs displayed before you complete your consultation. This competitive pricing includes the medication, clinical assessment, prescription issuance, and discreet home delivery to Fleet addresses. New patients can access an additional £20 discount using code Weightlossnew, reducing the initial cost to £124.99.

Unlike some providers who hide costs until after consultation, we believe Fleet residents deserve complete price transparency. Our pricing structure reflects genuine UK-licensed Mounjaro manufactured by Eli Lilly, not compounded or unlicensed alternatives that may pose safety risks. The MHRA has issued multiple warnings about unregulated tirzepatide products circulating online, emphasising the importance of sourcing from registered pharmacies [3].

Mounjaro Fleet patients should be aware that treatment is typically ongoing, with dosage escalation over several months. The starting dose of 2.5mg weekly gradually increases to maintenance doses of 5mg, 7.5mg, 10mg, 12.5mg, or 15mg, depending on individual response and tolerability. Our clinical team provides personalised dosing guidance throughout your weight loss journey, ensuring optimal results whilst managing potential side effects.

Why Choose Cured Pharmacy for Mounjaro Fleet Services?

Cured Pharmacy serves Fleet residents with a commitment to pharmaceutical excellence and patient care. Our GPhC registration (9012511) guarantees compliance with UK regulatory standards, whilst our experienced clinical team ensures every Mounjaro Fleet prescription meets strict safety criteria. We source exclusively from licensed UK wholesalers, eliminating the risk of counterfeit medications that plague unregulated online sellers.

Our service includes ongoing support throughout your treatment. Fleet patients can contact our pharmacy team on (+44) 116 4646009 for dosing questions, side effect management, or prescription renewals. This continuity of care distinguishes registered pharmacies from unregulated websites offering tirzepatide without proper medical oversight.

Mounjaro Fleet Prescription Requirements and Eligibility

Mounjaro Fleet prescriptions require clinical assessment by a UK-registered prescriber, as tirzepatide is a prescription-only medicine under UK law. Eligibility criteria align with MHRA licensing conditions: adults aged 18 or over with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1].

During your online consultation, Fleet patients answer detailed questions about medical history, current medications, previous weight loss attempts, and lifestyle factors. Our prescribers assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy. This thorough screening protects patient safety whilst ensuring Mounjaro is clinically appropriate.

Fleet residents with type 2 diabetes may already be familiar with GLP-1 receptor agonists, as these medications were originally developed for glycaemic control. However, Mounjaro's dual GIP/GLP-1 mechanism offers enhanced weight loss compared to single-agonist treatments like Wegovy (semaglutide) [4]. Our clinical team considers your complete medical profile when recommending the most suitable weight management option.

How to Use Mounjaro Fleet: Administration and Dosing Schedule

Mounjaro Fleet patients receive comprehensive administration guidance with their first prescription. The medication comes in pre-filled KwikPen injectors designed for subcutaneous injection into the abdomen, thigh, or upper arm. Each pen contains a single dose, and injections are administered once weekly on the same day each week, regardless of meal timing.

The standard Mounjaro Fleet dosing schedule begins with 2.5mg weekly for four weeks, allowing your body to adjust to the medication whilst minimising gastrointestinal side effects. After this initiation phase, the dose increases to 5mg weekly for four weeks, then escalates every four weeks through 7.5mg, 10mg, and 12.5mg, potentially reaching the maximum maintenance dose of 15mg. Clinical trials demonstrated that higher doses correlated with greater weight loss, though individual tolerability varies [2].

Fleet patients should store Mounjaro in the refrigerator between 2°C and 8°C, though unopened pens can remain at room temperature (not exceeding 30°C) for up to 21 days if needed. Never freeze the medication, and always inspect the solution before injecting—it should be clear and colourless. Our pharmacy team provides detailed injection technique videos and written instructions with every Mounjaro Fleet prescription.

Managing Mounjaro Fleet Side Effects

Common Mounjaro Fleet side effects include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, particularly during dose escalation phases. In the SURMOUNT trials, gastrointestinal adverse events were reported by 60-80% of participants, though most were mild to moderate and resolved within several weeks [2]. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise these symptoms.

Serious side effects requiring immediate medical attention include severe abdominal pain (potential pancreatitis), vision changes, persistent vomiting leading to dehydration, or signs of thyroid tumours such as neck lumps or difficulty swallowing. Fleet patients experiencing concerning symptoms should contact NHS 111 or their GP promptly. Our pharmacy team remains available to discuss side effect management and can liaise with your prescriber about dose adjustments if needed.

Mounjaro Fleet Results: What Weight Loss to Expect

Mounjaro Fleet patients can anticipate significant weight loss when combining the medication with lifestyle modifications. The SURMOUNT-1 trial demonstrated average weight reductions of 15.0% with 5mg, 19.5% with 10mg, and 20.9% with 15mg tirzepatide over 72 weeks [2]. These results represent averages—individual outcomes vary based on starting weight, adherence, dietary habits, physical activity, and metabolic factors.

Weight loss typically begins within the first month of Mounjaro Fleet treatment, with most patients noticing reduced appetite and smaller portion sizes. The gradual dose escalation allows your body to adapt whilst progressively enhancing weight loss effects. Clinical trials showed that approximately 91% of participants achieved at least 5% weight loss, whilst 55% achieved 20% or greater weight reduction at the highest dose [2].

Fleet residents should understand that Mounjaro is not a standalone solution but rather a tool to support comprehensive weight management. Combining the medication with balanced nutrition, regular physical activity, adequate sleep, and stress management optimises results. Our clinical team can provide referrals to registered dietitians or weight management programmes if additional support would benefit your journey.

Mounjaro Fleet Safety: Choosing Registered UK Pharmacies

Mounjaro Fleet safety depends critically on sourcing from legitimate UK-registered pharmacies like Cured Pharmacy. The MHRA has issued warnings about counterfeit tirzepatide products sold through unregulated websites and social media platforms, some containing incorrect doses, contaminants, or no active ingredient whatsoever [3]. These fake medications pose serious health risks including hypoglycaemia, severe allergic reactions, and treatment failure.

When ordering Mounjaro Fleet online, verify the pharmacy's GPhC registration number (ours is 9012511) on the General Pharmaceutical Council website. Legitimate pharmacies always require a valid prescription from a UK-registered prescriber following proper medical assessment. Be suspicious of websites offering tirzepatide without consultation, at prices significantly below market rates, or claiming to sell 'generic Mounjaro' (no generic version exists in the UK).

Cured Pharmacy guarantees 100% genuine UK-licensed Mounjaro manufactured by Eli Lilly. Every medication batch is traceable through our supply chain, and our superintendent pharmacist personally oversees quality control. Fleet patients receive medications in original manufacturer packaging with patient information leaflets, batch numbers, and expiry dates clearly displayed. This pharmaceutical integrity protects your health and ensures you receive the treatment outcomes demonstrated in clinical trials.

Mounjaro Fleet Long-Term Treatment Considerations

Mounjaro Fleet treatment is typically long-term, as weight regain commonly occurs after discontinuation. The SURMOUNT-4 trial examined participants who achieved significant weight loss on tirzepatide then either continued treatment or switched to placebo. Those continuing tirzepatide lost an additional 5.5% body weight over 52 weeks, whilst the placebo group regained 14.0% [5]. This data underscores the importance of ongoing treatment for weight maintenance.

Fleet patients should discuss long-term treatment plans with their prescriber, including periodic reviews to assess continued benefit, tolerability, and appropriateness. Some individuals may successfully transition to lower maintenance doses or incorporate structured lifestyle programmes to support weight stability. Our clinical team provides ongoing monitoring and can adjust your Mounjaro Fleet prescription based on your evolving needs and goals.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 3 October 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 3 October 2026]
3. Medicines and Healthcare products Regulatory Agency. (2024). Fake weight-loss medicines: MHRA warns of serious risks. MHRA Drug Safety Update. [accessed 3 October 2026]
4. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 3 October 2026]
5. Aronne, L. J., Sattar, N., Horn, D. B., et al. (2023). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38-48. [accessed 3 October 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 3 October 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 3 October 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 3 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.